Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Briers, Erik" or (type any "bookEditor issueEditor" and editor="Briers, Erik")

Add to list
- Journal Article
- A1
- open access
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Juan C. Rosas, Miguel E. Aguado‐Barrera, David Azria, Erik Briers, Rebecca Elliott, Marie‐Pierre Farcy‐Jacquet, Alexandra Giraldo, Sara Gutiérrez‐Enríquez, Tiziana Rancati, Tim Rattay, et al.

(2023) INTERNATIONAL JOURNAL OF CANCER. 153(9). p.1579-1591
Add to list
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Philipp Heumann, Miguel E. Aguado-Barrera, Barbara Avuzzi, David Azria, Erik Briers, Renée Bultijnck (UGent) , Ananya Choudhury, Dirk De Ruysscher, Marie-Pierre Farcy-Jacquet, Valerie Fonteyne (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 178.
Add to list
- Journal Article
- A1
- open access
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort

Adam J. Webb, Emily Harper, Tim Rattay, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, et al.

(2022) EBIOMEDICINE. 84.
Add to list
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Lotte van der Weijst (UGent) , David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 176. p.127-137
Add to list
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der Weijst (UGent) , Miguel E. Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, et al.

(2022) LUNG CANCER. 166. p.228-241
Add to list
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William Hall, Kim De Ruyck (UGent) , et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 168. p.75-82
Add to list
- Journal Article
- A1
- open access
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Paolo Zunino, Liv Veldeman (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , Christopher J. Talbot, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 159. p.241-248
Add to list
- Journal Article
- A1
- open access
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Ana Carballo, et al.

(2019) Radiotherapy and Oncology. 138. p.59-67

Academic Bibliography

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Contents

Support

Contact